These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872 [TBL] [Abstract][Full Text] [Related]
3. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling. Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138 [TBL] [Abstract][Full Text] [Related]
4. Attenuated acute cardiac rejection in NOS2 -/- recipients correlates with reduced apoptosis. Koglin J; Granville DJ; Glysing-Jensen T; Mudgett JS; Carthy CM; McManus BM; Russell ME Circulation; 1999 Feb; 99(6):836-42. PubMed ID: 9989972 [TBL] [Abstract][Full Text] [Related]
5. Prolonged survival of heart allografts from p53-deficient mice. Hu Y; Zou Y; Hala M; Dietrich H; Wick G; Xu Q Transplantation; 2000 Jun; 69(12):2634-40. PubMed ID: 10910287 [TBL] [Abstract][Full Text] [Related]
6. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts. Djamali A; Odorico JS Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278 [TBL] [Abstract][Full Text] [Related]
7. Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection. Haskova Z; Izawa A; Contreras AG; Flynn E; Boulday G; Briscoe DM Transplantation; 2007 Jun; 83(12):1595-601. PubMed ID: 17589343 [TBL] [Abstract][Full Text] [Related]
8. Spontaneous allograft tolerance in B7-deficient mice independent of preexisting endogenous CD4+CD25+ regulatory T-cells. Grazia TJ; Plenter RJ; Doan AN; Kelly BP; Weber SM; Kurche JS; Cushing SO; Gill RG; Pietra BA Transplantation; 2007 Jun; 83(11):1449-58. PubMed ID: 17565318 [TBL] [Abstract][Full Text] [Related]
9. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting. Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684 [TBL] [Abstract][Full Text] [Related]
10. Prolonged allograft survival in TNF receptor 1-deficient recipients is due to immunoregulatory effects, not to inhibition of direct antigraft cytotoxicity. McKee CM; Defina R; He H; Haley KJ; Stone JR; Perkins DL J Immunol; 2002 Jan; 168(1):483-9. PubMed ID: 11751996 [TBL] [Abstract][Full Text] [Related]
18. Donor microchimerism is not responsible for the maintenance of tolerance to donor alloantigens in recipients tolerant of cardiac allografts. Hamano K; Rawsthorne M; Bushell A; Morris PJ; Wood KJ Transplant Proc; 1995 Feb; 27(1):151-2. PubMed ID: 7878951 [No Abstract] [Full Text] [Related]
19. Survival of MHC deficient mouse heterotopic cardiac allografts and xenografts. Campos L; Deli BC; Kern JH; Kim JI; Naji A; Barker CF; Markmann JF Transplant Proc; 1995 Feb; 27(1):254-5. PubMed ID: 7878991 [No Abstract] [Full Text] [Related]
20. Heart, but not skin, allografts from donors lacking Flt3 ligand exhibit markedly prolonged survival time. Wang Z; Castellaneta A; De Creus A; Shufesky WJ; Morelli AE; Thomson AW J Immunol; 2004 May; 172(10):5924-30. PubMed ID: 15128773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]